Mahindra and Mahindra sees a ₹2,700 crore dent from Ssangyong and other global subsidiaries
- India’s third-largest auto maker reported a consolidated net loss of ₹3,255 crore between January and March 2020 compared to a profit of ₹840 crore a year earlier.
- If the one-time impact from Ssangyong and other global subsidiaries is taken out, the bottomline would have shown a profit after tax of ₹323 crore.
- The stock gained nearly 8% in trade as M&M’s performance far exceeded the estimates, as well as those of its peers like Maruti and Tata Motors.
“The Company has recognised a loss of ₹2,780.47 crore as 'Exceptional items' on account of impairment provision for certain long-term investment,” the statement said.
The profit after tax, before these exceptional items, stood at ₹323 crore, leading the market to cheer— the stock ended the day up over 7.5% — and the board declared a dividend of ₹2.35 per share of the face value of ₹5 each.
The company’s total revenue was down 35% year-on-year to ₹9,005 crore. The profit was still the worst in at least five quarters.
Better than peers
The Mahindra group company had the benefit of catering to the farm sector at a time when the coronavirus lockdown had brought the urban demand for cars— particularly the more expensive SUVs that M&M specialises in — to a standstill. The company said the timely relaxation of the lockdown for the agricultural sector helped the company to ensure the gradual recovery of tractor demand during May.
And that’s a reason why it has also been the better of the country’s auto stocks this year.
|Stock||Growth since Dec 31|
SEE ALSO: Mahindra & Mahindra investors hope tractors will save the day— and the year
After Maruti and Hyundai, Tata Motors offers discounts as car makers get squeezed between slow sales and slower registrations
- UP to have cold chain space for 1.23L litres of vaccine
- Wuhan authorities now find Covid-19 on imported frozen food
- From WhiteHat Jr, Big Basket, and Unacademy to Dunzo — these are the Indian startups that reported data leaks over the past few months
- Chennai volunteer for SII's Covid vaccine claims Rs 5 cr compensation for health complications
- ASEAN distances from China's Covid vaccine diplomacy